The effect of lamotrigine on naloxone-precipitated opiate withdrawal

Drug and Alcohol Dependence

Volumn 52, Issue 2, 1998, Pages 173-176

  Rosen, Marc I ^a   Rowland Pearsall, H ^a   R Kosten, Thomas ^a  

^a YALE UNIVERSITY   (United States)

Author keywords

Excitatory amino acid; Lamotrigine; Opioid; Withdrawal

Indexed keywords

EXCITATORY AMINO ACID; LAMOTRIGINE; LEVORPHANOL; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NALOXONE; NEUROTRANSMITTER; OPIATE AGONIST; PLACEBO;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG INHIBITION; DRUG TOLERANCE; DRUG WITHDRAWAL; HUMAN; HUMAN EXPERIMENT; HYPOTHESIS; INTRAVENOUS DRUG ADMINISTRATION; MALE; OPIATE ADDICTION; ORAL DRUG ADMINISTRATION; PATIENT COMPLIANCE; PRIORITY JOURNAL; RASH;

ADULT; ANALGESICS; DOUBLE-BLIND METHOD; FEMALE; HEROIN DEPENDENCE; HUMANS; INFUSIONS, INTRAVENOUS; MALE; NALOXONE; NARCOTIC ANTAGONISTS; NEUROLOGIC EXAMINATION; SUBSTANCE WITHDRAWAL SYNDROME; TRIAZINES;

EID: 0345404297     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0376-8716(98)00057-X     Document Type: Article

References (15)

1. Brodie, M.J., Richens, A., Yuen, A.W.C. for UK Lamotrigine/Carbamazepine Monotherapy Trial Group, 1995. Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy. Lancet 345, 476-479.
2. Cohen A., Land G., Breimer D., Yuen W., Winton C., Peck A. Lamotrigine, a new anticonvulsant: pharmacokinetics in normal humans. Clin. Pharmacol. Ther. 42(5):1987;535-541.
3. Fertziger A.P., Lynch J.J., Stein E. Modification of the morphine withdrawal syndrome in rats. Brain Res. 78:1974;331-334.
4. Higgins G.A., Nguyen P., Sellers E.M. The NMDA antagonist dizocilipine (MK801) attenuates motivational as well as somatic aspects of naloxone precipitated opioid withdrawal. Life Sci. 50:1992;PL167-PL172.
5. Jawad S., Oxley J., Yuen W.C., Richens A. The effect of lamotrigine, a novel anticonvulsant, on interictal spikes in patients with epilepsy. Br. J. Clin. Pharmacol. 22:1986;191-193.
6. Lang D.G., Wang C.M., Cooper B.R. Lamotrigine, phenytoin and carbamazepine interactions on the sodium current present in N4TG1 mouse neuroblastoma cells. J. Pharmacol. Exp. Ther. 266(2):1993;829-835.
7. Lees G., Leech M.J. Studies on the mechanism of action of the novel anticonvulsant lamotrigine (Lamictal) using primary neuroglial cultures from rat cortex. Brain Res. 612:1993;190-199.
8. Nakamura-Craig M., Follenfant R.L. Effect of lamotrigine in the acute and chronic hyperalgesia induced by PGE2 and in the chronic hyperalgesia in rats with streptozocin-induced diabetes. Pain. 63:1995;33-37.
9. Rasmussen K., Kendrick W.T., Kogan J.H., Aghajanian G.K. A selective AMPA antagonist, LY 293558, suppresses morphine withdrawal-induced activation of locus coeruleus neurons and behavioral signs of morphine withdrawal. Neuropsychopharmacology. 15:1996;497-505.
10. Rosen M., McMahon T.J., Hameedi F.A., Pearsall H.R., Woods S., Kreek M.J., Kosten T. Effect of clonidine pretreatment on naloxone-precipitated opiate withdrawal. J. Pharmacol. Exp. Ther. 276(3):1996;1128-1135.
11. Rosen M., Pearsall H., Woods S., Kosten T. The effect of gamma-hydroxybutyric acid on naloxone-precipitated opiate withdrawal. Neuropsychopharmacology. 14:1996;187-193.
12. Trujillo K.A., Akil H. Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801. Science. 251:1990;85-87.
13. Waldmeier P.C., Baumann P.A., Wicki P., Feldtrauer J.J., Stierlin C., Schmutz M. Similar potency of carbamazepine, oxcarbazepine, and lamotrigine in inhibiting the release of glutamate and other neurotransmitters. Neurology. 45(10):1995;1907-1913.
14. Willets J., Balster R.L., Leander J.D. The behavioral pharmacology of NMDA receptor antagonists. Trends Pharmacol. Sci. 11:1990;423-428.
15. Wirard R.P., Dickerson M.C., Beck O., Norton R., Cooper B.R. Neuroprotective properties of the novel antiepileptic lamotrigine in a gerbil model of global cerebral ischemia. Stroke. 26(3):1995;466-472.